Skip to main content

Table 1 Patient characteristics

From: Clinical utility of linear endosonography in patients with unexplained biliary dilatation and negative MRCP, with predictors for detection of neoplastic lesions

  Number Percentage
Age/years 60 (21–82)
Sex
 • Male 29 47.5
 • Female 32 52.6
Clinical presentation
 • Jaundice 43 70.5
 • Upper abdominal pain 10 16.4
 • Incidental biliary dilatation 8 13.1
History of cholecystectomy 6 9.8
Laboratory data
 • Bilirubin (total) (mg/dl) 2.8 (0.4–39)
 • ALT (IU/l) 49 (11–293)
 • AST (IU/l) 47 (19–288)
 • Alkaline phosphatase (mg/dl) 223.0 (47–1260 )
 • Tumor markers
  CA19-9 39.0 (0.60–1200)
  CEA 2.69 (0.4–15.05)
  1. Data are expressed as mean ± SD, median (range), or n (%)
  2. ALT Alanine transaminase, AST Aspartate aminotransferase, CA19-9 Carbohydrate antigen 19-9, CEA Carcinoembryonic antigen